The First New TB Drug Since 1963 Approved

January 15, 2013

The first new drug approved to treat tuberculosis (TB) since 1963 could result in shorter treatment with less side effects and the opportunity to treat more people. For people with drug-resistant TB, it could present a new lifeline.

 

Tags: Tuberculosis, Access to Medicines

Podcast » A Doctor Returns to Somaliland

Video » Trans-Pacific Trade Pact: Hands Off Our Medicines

Open Letters » MSF Open Letter: Words Must be Turned into Humanitarian Action for Syrians

Slideshow » Surviving Two Years of Treatment for Drug-Resistant TB in Kyrgyzstan

Special Report » Healing Iraqis: The Challenges of Providing Mental Health Care in Iraq

About Us | Field News | Contact Us | Donate | MSF Offices Worldwide

This site is maintained by the U.S. section of Doctors Without Borders/Médecins Sans Frontières (MSF), an international independent medical humanitarian organization that delivers emergency aid to people affected by armed conflict, epidemics, natural and man-made disasters, and exclusion from health care. © 2013 MSF All rights reserved.

Doctors Without Borders is approved by the Internal Revenue Service as a 501 (C) (3) tax-exempt organization, and all donations are tax deductible to the extent provided by law. Doctors Without Borders Federal Identification Number (EIN) is 13-3433452.

MSF-USA Association | Copyright Statement | Privacy Policy

333 7th Avenue, New York, NY 10001-5004. Phone: 212-679-6800